Developed 3-D nano networks, “nanosponges” can be tailored in their size, linear release profile of drugs and are easily functionalized with targeting, labeling and cell penetrating units. Hydrophobic drug molecules can be incorporated in a postloading procedure, allowing for single and multi-drug incorporation. The resulting particles are well dispersed in aqueous solutions for in vitro […]
This author has yet to write their bio.Meanwhile lets just say that we are proud admin contributed a whooping 2 entries.
Entries by admin
Polyglycidol macromolecules are optimized and to work in bioconjugates and composite materials. Delivery materials that enable the synergistic therapeutic effect of proteins and synthetic molecules are developed in novel hydrogel materials and particles to develop the next generation of delivery devices.
Dr. Eva M. Harth
Harth Research Lab
7665 Stevenson Center
Internal Mail: VU Station B, Box 351822
Nashville, TN 37235
Phone: (615) 343-3405
Phone on campus: 3-3405
FAX: (615) 343-5478
FAX on campus: 3-5478
Recent NewsApril 27, 2017: Laken Kendrick-William’s JOVE paper accepted. Congratulations!
April 21, 2017: 7 patents of the Harth patent family were sold or licensed today!
March 09, 2017: 5th issued patent for the Harth Group: 9,580,548 “Polycarbonate Containing Compounds and Methods Related Thereto”